Screening of brain metastasis with limited magnetic resonance imaging

REFERENCES
1. Heelan R. Lung cancer imaging: primary diagnosis, staging, and local
recurrence. Semin Oncol 1991;18:87–98.
2. McCarthy M, Ros P, Sobin L. Scientific exhibit-carcinoma of the
lung: updated imaging-pathologic correlations. Radial Soc N Am 1985:
17–22.
3. Zwirewich CV, Miller RR, Müller NL. Multicentric adenocarcinoma
of the lung: CT-pathologic correlation. Radiology 1990;176:185–190.
4. Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer
screening experience: CT appearance, growth rate, location, and histologic
features of 61 lung cancers. Radiology 2007;242:555–562.
5. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers
detected on mass CT screening. Br J Radiol 2000;73:1252–1259.
6. Felson B, Wiot JF. Some less familiar roentgen manifestations of carcinoma
of the lung. Semin Roentgenol 1977;12:187–206.
7. Woodring JH. Unusual radiographic manifestations of lung cancer.
Radiol Clin North Am 1990;28:599–618.
8. Austin JH, Romney BM, Goldsmith LS. Missed bronchogenic carcinoma:
radiographic findings in 27 patients with a potentially resectable
lesion evident in retrospect. Radiology 1992;182:115–122.
9. Shah PK, Austin JH, White CS, et al. Missed non-small cell lung cancer:
radiographic findings of potentially resectable lesions evident only
in retrospect. Radiology 2003;226:235–241.
10. Sakai S, Soeda H, Takahashi N, et al. Computer-aided nodule detection
on digital chest radiography: validation test on consecutive T1
cases of resectable lung cancer. J Digit Imaging 2006;19:376–382.
11. Ide K, Mogami H, Murakami T, et al. Detection of lung cancer using
single-exposure dual-energy subtraction chest radiography. Radiat Med
2007;25:195–201.
12. Tsubamoto M, Kuriyama K, Kido S, et al. Detection of lung cancer on
chest radiographs: analysis on the basis of size and extent of groundglass
opacity at thin-section CT. Radiology 2002;224:139–144.
13. Li F, Sone S, Abe H, et al. Lung cancers missed at low-dose helical CT
screening in a general population: comparison of clinical, histopathologic,
and imaging findings. Radiology 2002;225:673–683.
14. Armato SG III, Li F, Giger ML, et al. Lung cancer: performance of
automated lung nodule detection applied to cancers missed in a CT
screening program. Radiology 2002;225:685–692.
15. Wiemker R, Rogalla P, Blaffert T, et al. Aspects of computer-aided detection
(CAD) and volumetry of pulmonary nodules using multislice
CT. Br J Radiol 2005;78 Spec No 1:S46–S56.
16. Das M, Mühlenbruch G, Mahnken AH, et al. Small pulmonary nodules:
effect of two computer-aided detection systems on radiologist performance.
Radiology 2006;241:564–571.
17. Gruden JF, Ouanounou S, Tigges S, et al. Incremental benefit of
maximum-intensity-projection images on observer detection of small
pulmonary nodules revealed by multidetector CT. AJR Am J Roentgenol
2002;179:149–157.
18. Peloschek P, Sailer J, Weber M, et al. Pulmonary nodules: sensitivity of
maximum intensity projection versus that of volume rendering of 3D
multidetector CT data. Radiology 2007;243:561–569.
19. Muhm J, Miller WE, Fontana RS, et al. Lung cancer detected during
a screening program using four-month chest radiographs. Radiology
1983;148:609–615.
20. Hendrix RW. In defense of a missed lesion. Radiology 1995;195:
578–579.
21. Berlin L. Failure to diagnose lung cancer: anatomy of a malpractice
trial. AJR Am J Roentgenol 2003;180:37–45.
22. Good CA, Hood RT Jr, McDonald JR. Significance of a solitary
mass in the lung. Am J Roentgenol Radium Ther Nucl Med 1953;70:
543–554.
23. Davis EW, Katz S, Peabody JW Jr. The solitary pulmonary nodule; a
ten-year study based on 215 cases. J Thorac Surg 1956;32:728–770.
24. Walske B. The solitary pulmonary nodule. Dis Chest 1956;49:
302–304.
25. Taylor RR, Rivkin LN, Salyer JM. The solitary pulmonary nodule; a review
of 236 consecutive cases, 1944 to 1956. Ann Surg 1958;147:197–202.
26. Steele JD. The solitary pulmonary nodule. Report of a cooperative
study of resected asymptomatic solitary pulmonary nodules in males.
J Thorac Cardiovasc Surg 1963;46:21–39.
27. Siegelman SS, Zerhouni EA, Leo FP, et al. CT of the solitary pulmonary
nodule. AJR Am J Roentgenol 1980;135:1–13.
28. Petrou M, Quint LE, Nan B, et al. Pulmonary nodule volumetric measurement
variability as a function of CT slice thickness and nodule
morphology. AJR Am J Roentgenol 2007;188:306–312.
29. Quint LE, Cheng J, Schipper M, et al. Lung lesion doubling times:
values and variability based on method of volume determination. Clin
Radiol 2008;63:41–48.
30. Winer-Muram HT, Jennings SG, Meyer CA, et al. Effect of varying
CT section width on volumetric measurement of lung tumors and application
of compensatory equations. Radiology 2003;229:184–194.
31. Boll DT, Gilkeson RC, Fleiter TR, et al. Volumetric assessment of
pulmonary nodules with ECG-gated MDCT. AJR Am J Roentgenol
2004;183:1217–1223.
32. Zhao B, Schwartz LH, Moskowitz CS, et al. Pulmonary metastases:
effect of CT section thickness on measurement—initial experience.
Radiology 2005;234:934–939.
33. Goo JM, Tongdee T, Tongdee R, et al. Volumetric measurement of synthetic
lung nodules with multi-detector row CT: effect of various image
reconstruction parameters and segmentation thresholds on measurement
accuracy. Radiology 2005;235:850–856.
34. Wormanns D, Kohl G, Klotz E, et al. Volumetric measurements of
pulmonary nodules at multi-row detector CT: in vivo reproducibility.
Eur Radiol 2004;14:86–92.
35. Kostis WJ, Yankelevitz DF, Reeves AP, et al. Small pulmonary nodules:
reproducibility of three-dimensional volumetric measurement and estimation
of time to follow-up CT. Radiology 2004;231:446–452.
36. Revel MP, Lefort C, Bissery A, et al. Pulmonary nodules: preliminary experience
with three-dimensional evaluation. Radiology 2004;231:459–466.
37. Yankelevitz DF, Gupta R, Zhao B, et al. Small pulmonary nodules:
evaluation with repeat CT—preliminary experience. Radiology 1999;
212:561–566.
38. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Small pulmonary nodules:
volumetrically determined growth rates based on CT evaluation.
Radiology 2000;217:251–256.
39. Winer-Muram HT, Jennings SG, Tarver RD, et al. Volumetric growth
rate of stage I lung cancer prior to treatment: serial CT scanning.
Radiology 2002;223:798–805.
40. Revel MP, Merlin A, Peyrard S, et al. Software volumetric evaluation of
doubling times for differentiating benign versus malignant pulmonary
nodules. AJR Am J Roentgenol 2006;187:135–142.
41. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management
of small pulmonary nodules detected on CT scans: a statement
from the Fleischner Society. Radiology 2005;237:395–400.
42. Winer-Muram HT. The solitary pulmonary nodule. Radiology 2006;
239:34–49.
43. Strunk H, Schweden F, Schild H, et al. Spiral CT with 3D surface reconstruction
in assessing solitary pulmonary foci. Rofo 1993;158:26–30.
44. Berger WG, Erly WK, Krupinski EA, et al. The solitary pulmonary
nodule on chest radiography: can we really tell if the nodule is calcified?
AJR Am J Roentgenol 2001;176:201–204.
45. Sherrier RH, Chiles C, Johnson GA, et al. Differentiation of benign
from malignant pulmonary nodules with digitized chest radiographs.
Radiology 1987;162:645–649.
46. Gilkeson RC, Sachs PB. Dual energy subtraction digital radiography:
technical considerations, clinical applications, and imaging pitfalls.
J Thorac Imaging 2006; 21:303–313.
47. Siegelman SS, Khouri NF, Scott WW Jr, et al. Pulmonary hamartoma:
CT findings. Radiology 1986;160:313–317.
48. Grewal RG, Austin JH. CT demonstration of calcification in carcinoma
of the lung. J Comput Assist Tomogr 1994;18:867–871.
49. Chong S, Lee KS, Chung MJ, et al. Neuroendocrine tumors of the
lung: clinical, pathologic, and imaging findings. Radiographics 2006;26:
41–57; discussion 57–48.
50. Swensen S, Brown LR, Colby TV, et al. Pulmonary nodules: CT
evaluation of enhancement with iodinated contrast material. Radiology
1995;194:393–398.
51. Yamashita K, Matsunobe S, Tsuda T, et al. Solitary pulmonary nodules:
preliminary study of evaluation with incremental dynamic CT.
Radiology 1995;194:399–405.
52. Swensen SJ, Brown LR, Colby TV, et al. Lung nodule enhancement at
CT: prospective findings. Radiology 1996;201:447–455.
53. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement
at CT: multicenter study. Radiology 2000;214:73–80.
54. Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic
enhanced multi-detector row CT study and comparison with vascular
endothelial growth factor and microvessel density. Radiology 2004;
233:191–199.
55. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood
flow patterns with dynamic CT. Radiology 1997;205:471–478.
56. Jeong YJ, Lee KS, Jeong SY, et al. Solitary pulmonary nodule: characterization
with combined wash-in and washout features at dynamic
multi-detector row CT. Radiology 2005;237:675–683.
57. Lee KS, Yi CA, Jeong SY, et al. Solid or partly solid solitary pulmonary
nodules: their characterization using contrast wash-in and morphologic
features at helical CT. Chest 2007;131:1516–1525.
58. Yi CA, Lee KS, Kim BT, et al. Efficacy of helical dynamic CT versus
integrated PET/CT for detection of mediastinal nodal metastasis in
non-small cell lung cancer. AJR Am J Roentgenol 2007;188:318–325.
59. Schroeder T, Ruehm SG, Debatin JF, et al. Detection of Pulmonary
Nodules Using a 2D HASTE MR Sequence: Comparison with MDCT.
Am J Roentgenol 2005;185:979–984.
60. Gückel C, Schnabel K, Deimling M, et al. Solitary pulmonary nodules:
MR evaluation of enhancement patterns with contrast-enhanced dynamic
snapshot gradient-echo imaging. Radiology 1996;200:681–686.
61. Ohno Y, Hatabu H, Takenaka D, et al. Solitary pulmonary nodules:
potential role of dynamic MR imaging in management initial experience.
Radiology 2002;224:503–511.
62. Schaefer JF, Schneider V, Vollmar J, et al. Solitary pulmonary nodules:
Association between signal characteristics in dynamic contrast
enhanced MRI and tumor angiogenesis. Lung Cancer 2006;53:39–49.
63. Kono M, Adachi S, Kusumoto M, et al. Clinical utility of Gd-DTPAenhanced
magnetic resonance imaging in lung cancer. J Thorac Imaging
1993;8:18–26.
64. Sakai F, Sone S, Maruyama A, et al. Thin-rim enhancement in Gd-
DTPA-enhanced magnetic resonance images of tuberculoma: a new
finding of potential differential diagnostic importance. J Thorac
Imaging 1992;7:64–69.
65. Ohno Y, Hatabu H, Takenaka D, et al. CT-guided transthoracic needle
aspiration biopsy of small ( or 20 mm) solitary pulmonary nodules.
AJR Am J Roentgenol 2003;180:1665–1669.
66. Romano M, Griffo S, Gentile M, et al. CT guided percutaneous fine
needle biopsy of small lung lesions in outpatients. Safety and efficacy
of the procedure compared to inpatients. Radiol Med 2004;108:
275–282.
67. Savage C, Walser EM, Schnadig V, et al. Transthoracic image-guided
biopsy of lung nodules: when is benign really benign? J Vasc Interv
Radiol 2004;15:161–164.
68. Yamagami T, Iida S, Kato T, et al. Usefulness of new automated cutting
needle for tissue-core biopsy of lung nodules under CT fluoroscopic
guidance. Chest 2003;124:147–154.
69. Quint LE, Kretschmer M, Chang A, et al. CT-guided thoracic core
biopsies: value of a negative result. Cancer Imaging 2006;6:163–167.
70. Montaudon M, Latrabe V, Pariente A, et al. Factors influencing accuracy
of CT-guided percutaneous biopsies of pulmonary lesions. Eur
Radiol 2004;14:1234–1240.
71. Satoh S, Ohdama S, Matsubara O, et al. CT-guided automated cutting
needle biopsy by a combined method for accurate specific diagnosis of
focal lung lesions. Radiat Med 2005;23:30–36.
72. Klein J, Salomon G, Stewart E. Transthoracic needle biopsy with a
coaxially placed 20-gauge automated cutting needle: results in 122 patients.
Radiology 1996;198:715–720.
73. Hayashi N, Sakai T, Kitagawa M, et al. CT-guided biopsy of pulmonary
nodules less than 3 cm: usefulness of the spring-operated core biopsy
needle and frozen-section pathologic diagnosis. AJR Am J Roentgenol
1998;170:329–331.
74. Cahan WG, Shah JP, Castro EB. Benign solitary lung lesions in patients
with cancer. Ann Surg 1978;187:241–244.
75. Quint LE, Park CH, Iannettoni MD. Solitary pulmonary nodules in
patients with extrapulmonary neoplasms. Radiology 2000;217:257–261.
76. Quint LE. Staging non-small cell lung cancer. Cancer Imaging 2007;
7:148–159.
77. AJCC Cancer Staging Handbook. New York: Springer-Verlag, 2002.
78. Mountain CF. Staging classification of lung cancer. A critical evaluation.
Clin Chest Med 2002;23:103–121.
79. Mountain CF. Revisions in the International System for Staging Lung
Cancer. Chest 1997;111:1710–1717.
80. Mountain CF, Dresler CM. Regional lymph node classification for
lung cancer staging. Chest 1997;111:1718–1723.
81. Sobin L, Wittekind C, eds. TNM Classification of Malignant Tumours ,
6th ed. New York: Wiley-Liss, 2002.
82. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for the revision of the TNM stage groupings
in the forthcoming (seventh) edition of the TNM Classification of
malignant tumours. J Thorac Oncol 2007;2:706–714.
83. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer
Staging Project: validation of the proposals for revision of the T, N,
and M descriptors and consequent stage groupings in the forthcoming
(seventh) edition of the TNM classification of malignant tumours.
J Thorac Oncol 2007;2:694–705.
84. Postmus PE, Brambilla E, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for revision of the M descriptors in the forthcoming
(seventh) edition of the TNM classification of lung cancer.
J Thorac Oncol 2007;2:686–693.
85. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer
Staging Project: proposals for the revision of the T descriptors in the
forthcoming (seventh) edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:593–602.
86. Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer
Staging Project: proposals for the revision of the N descriptors in the
forthcoming seventh edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:603–612.
87. Murayama S, Murakami J, Yoshimitsu K, et al. CT diagnosis of pleural
dissemination without pleural effusion in primary lung cancer. Radiat
Med 1996;14:117–119.
88. Gdeedo A, Van Schil P, Corthouts B, et al. Comparison of imaging
TNM [(i)TNM] and pathological TNM [(p)TNM] in staging of bronchogenic
carcinoma. European Jounal of Cardio-Thoracic Surgery 1997;
12:224–227.
89. Glazer HS, Duncan-Meyer J, Aronberg DJ. Pleural and chest wall invasion
in bronchogenic carcinoma: CT evaluation. Radiology 1985;157:
191–194.
90. Pennes DR, Glazer GM, Wimbish KJ, et al. Chest wall invasion by
lung cancer: limitations of CT evaluation. AJR Am J Roentgenol 1985;
144:507–511.
91. Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung
cancer: computed tomographic detection and results of operation. Ann
Thorac Surg 1991;51:182–188.
92. Venuta F, Rendina E, Ciriaco P, et al. Computed tomography for preoperative
assessment of T3 and T4 bronchogenic carcinoma. Eur J
Cardiothorac Surg 1992;6:238–241.
93. Rendina EA, Bognolo DA, Mineo TC, et al. Computed tomography
for the evaluation of intrathoracic invasion by lung cancer. J Thorac
Cardiovasc Surg 1987;94:57–63.
94. Pearlberg JL, Sandler MA, Beute GH, et al. Limitations of CT in
evaluation of neoplasms involving chest wall. J Comput Assist Tomogr
1987;11:290–293.
95. Watanabe A, Shimokata K, Saka H, et al. Chest CT combined with
artificial pneumothorax: value in determining origin and extent of
tumor. AJR Am J Roentgenol 1991;156:707–710.
96. Yokoi K, Mori K, Miyazawa N, et al. Tumor invasion of the chest wall
and mediastinum in lung cancer: evaluation with pneumothorax CT.
Radiology 1991;181:147–152.
97. Yokozaki M, Nawano S, Nagai K, et al. Cine magnetic resonance imaging,
computed tomography and ultrasonography in the evaluation of
chest wall invasion of lung cancer. Hiroshima J Med Sci 1997;46:61–66.
98. Murata K, Takahashi M, Mori M, et al. Chest wall and mediastinal invasion
by lung cancer: evaluation with multisection expiratory dynamic
CT. Radiology 1994;191:251–255.
99. Suzuki N, Saito T, Kitamura S. Tumor invasion of chest wall in lung
cancer: diagnosis with US. Radiology 1993;187:39–42.
100. Piehler JM, Pairolero PC, Weiland LH, et al. Bronchogenic carcinoma
with chest wall invasion: factors affecting survival following en bloc
resection. Ann Thoracic Surg 1982;34:684–691.
101. Paone JF, Spees EK, Newton CG, et al. An appraisal of en bloc resection
of peripheral bronchogenic carcinoma involving the thoracic wall.
Chest 1982;81:203–207.
102. Glazer HS, Kaiser LR, Anderson DJ. Indeterminate mediastinal invasion
in brochogenic carcinoma: CT evaluation. Radiology 1989;173:37–42.
103. Würsten H, Vock P. Mediastinal infiltration of lung carcinoma
(T4NO-1): the positive predictive value of computed tomography.
Thorac Cardiovasc Surg 1987;35:355–360.
104. Kameda K, Adachi S, Kono M. Detection of T-factor in lung cancer
using magnetic resonance imaging and computed tomography. J Thorac
Imag 1988;3:73–80.
105. Izbicki JR, Thetter O, Karg O, et al. Accuracy of computed tomographic
scan and surgical assessment for staging of bronchial carcinoma.
A prospective study. J Thorac Cardiovasc Surg 1992;104:413–420.
106. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in
staging non-small cell bronchogenic carcinma: report of the radiologic
diagnostic oncology group. Radiology 1991;178:705–713.
107. Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional,
computed tomographic, and magnetic resonance imaging in
assessing mediastinal involvement in surgically confirmed lung carcinoma.
J Thorac Cardiovasc Surg 1985;90:639–648.
108. Musset D, Grenier P, Carette MF. Primary lung cancer staging: prospective
comparative study of MR imaging with CT. Radiology 1986;160:
607–611.
109. Laurent F, Drouillard J, Dorcier F, et al. Bronchogenic carcinoma
staging: CT versus MR imaging. Assessment with surgery. Eur J
Cardiothorac Surg 1988;2:31–36.
110. Choe DH, Lee JH, Lee BH, et al. Obliteration of the pulmonary vein
in lung cancer: significance in assessing local extent with CT. J Comput
Assist Tomogr 1998;22:587–591.
111. Schröder C, Schönhofer B, Vogel B. Transesophageal echographic determination
of aortic invasion by lung cancer. Chest 2005;127:438–442.
112. Quint LE, Glazer GM, Orringer MB. Central lung masses: prediction
with CT of need for pneumonectomy versus lobectomy. Radiology
1987;165:735–738.
113. Hu Y, Malthaner RA. The feasibility of three-dimensional displays of
the thorax for preoperative planning in the surgical treatment of lung
cancer. Eur J Cardiothorac Surg 2007;31:506–511.
114. Quint LE, McShan DL, Glazer GM, et al. Three dimensional CT of
central lung tumors. Clin Imaging 1990;14:323–329.
115. Tobler J, Levitt RG, Glazer HS, et al. Differentiation of proximal bronchogenic
carcinoma from post-obstructive lobar collapse by magnetic
resonance imaging: comparison with computed tomography. Invest
Radiol 1987;22:538–543.
116. Kirsh MM, Kahn DR, Gago O, et al. Treatment of bronchogenic carcinoma
with mediastinal metastases. Ann Thorac Surg 1971;12:11–21.
117. Martini N, Flehinger BJ, Zaman MB, et al. Results of resection in nonoat
cell carcinoma of the lung with mediastinal lymph node metastases.
Ann Surg 1983;198:386–397.
118. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability
at various levels of metastasis in resected lung cancer. J Thorac
Cardiovasc Surg 1978;76:832–839.
119. Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention
in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991;41:
253–261.
120. Mountain CF. Expanded possibilities for surgical treatment of lung
cancer. Chest 1990;97:1045–1051.
121. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected
lung carcinoma based on the new international staging system. J Thorac
Cardiovasc Surg 1988;96:440–447.
122. McKenna RJ Jr, Libshitz HI, Mountain CE, et al. Roentgenographic
evaluation of mediastinal nodes for preoperative assessment in lung
cancer. Chest 1985;88:206–210.
123. Pearson FG, DeLarue NC, Ilves R, et al. Significance of positive superior
mediastinal nodes identified at mediastinoscopy in patients with
resectable cancer of the lung. J Thorac Cardiovasc Surg 1982;83:1–11.
124. Martini N, Flehinger B. The role of surgery in N2 lung cancer. Surg
Clin North Am 1987;67:1037–1049.
125. Patterson GA, Piazza D, Pearson FG, et al. Significance of metastatic
disease in subaortic lymph nodes. Ann Thorac Surg 1987;43:155–159.
126. Patel V, Shrager JB. Which patients with stage III non-small cell lung
cancer should undergo surgical resection? Oncologist 2005;10:335–344.
127. Taylor SG IV, Trybula M, Bonomi PD, et al. Simultaneous cisplatin
fluorouracil infusion and radiation followed by surgical resection in regionally
localized stage III, non-small cell lung cancer. Ann Thorac Surg
1987;43:87–91.
128. Faber L, Kittle C, Warren W. Preoperative chemotherapy and irradiation
for stage III non-small cell lung cancer. Ann Thorac Surg
1989;47:669–677.
129. Skarin A, Jochelson M, Sheldon T. Neoadjuvant chemotherapy in marginally
resectable stage III M0 non-small cell lung cancer: long-term
follow-up in 41 patients. J Surg Oncon 1989;40:266–274.
130. Sugarbaker D, Herndon J, Kohman L, et al. Results of Cancer and
Leukemia Group B protocol 8935: a multi-institutional phase II trimodality
trial of stage HIA (N2) non-small cell lung cancer. J Thorac
Cardiovasc Surg 1995;109:473–485.
131. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing
perioperative chemotherapy and surgery with surgery done in resectable
stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994;86:
673–680.
132. Rosell R, Gómez-Codina J, Camps C, et al. A randomized trial comparing
chemotherapy plus surgery with surgery alone in patients with
non-small cell lung cancer. N Engl J Med 1994;330:153–158.
133. Glazer GM, Gross BH, Quint LE, et al. Normal mediastinal lymph
nodes: number and size according to American thoracic society mapping.
AJR Am J Roentgenol 1985;144:261–265.
134. Quint LE, Glazer GM, Orringer MB, et al. Mediastinal lymph
node detection and sizing at CT and autopsy. AJR Am J Roentgenol
1986;147:469–472.
135. Shimoyama K, Murata K, Takahashi M, et al. Pulmonary hilar lymph
node metastases from lung cancer: evaluation based on morphology at
thin-section, incremental dynamic CT. Radiology 1997;203:187–195.
136. Genereux GP, Howie JL. Normal mediastinal lymph node size and number:
CT and anatomic study. AJR Am J Roentgenol 1984;142:1095–1100.
137. Schnyder PA, Gamsu G. CT of the pretracheal retrocaval space. AJR
Am J Roentgenol 1981;136:303–308.
138. Kiyono K, Sone S, Sakai F, et al. The number and size of normal
mediastinal lymph nodes: a postmortem study. AJR Am J Roentgenol
1988;150:771–776.
139. Glazer GM, Orringer MB, Gross BH, et al. The mediastinum in nonsmall
cell lung cancer: CT-surgical correlation. AJR Am J Roentgenol
1984;142:1101–1105.
140. Platt JF, Glazer GM, Orringer MB, et al. Radiologic evaluation of the
subcarinal lymph nodes: a comparative study. AJR Am J Roentgenol
1988;151:279–282.
141. Medina Gallardo JF, Borderas Naranjo F, Torres Cansino M, et al.
Validity of enlarged mediastinal nodes as markers of involvement by
non-small cell lung cancer. Am Rev Respir Dis 1992;146:1210–1212.
142. Daly BJ Jr, Faling LJ, Pugatch RD, et al. Computed tomography. An
effective technique for mediastinal staging in lung cancer. J Thorac
Cardiovasc Surg 1984;88:486–494.
143. Gross BH, Glazer GM, Orringer MB, et al. Bronchogenic carcinoma
metastatic to normal-sized lymph nodes: frequency and significance.
Radiology 1988;166:71–74.
144. Arita T, Matsumoto T, Kuramitsu T, et al. Is it possible to differentiate
malignant mediastinal nodes from benign nodes by size? Reevaluation
by CT, transesophageal echocardiography, and nodal specimen. Chest
1996;110:1004–1008.
145. Pretreatment evaluation of non-small-cell lung cancer. The American
Thoracic Society and The European Respiratory Society. Am J Respir
Crit Care Med 1997;156:320–332.
146. Faling LJ, Pugatch RD, Jung-Legg Y, et al. Computed tomographic
scanning of the mediastinum in the staging of bronchogenic carcinoma.
Am Rev Respir Dis 1981;124:690–695.
147. Cybulsky IJ, Lanza LA, Ryan MB, et al. Prognostic significance of
computed tomography in resected N2 lung cancer. Ann Thorac Surg
1992;54:533–537.
148. Ishida T, Tateishi M, Kaneko S, et al. Surgical treatment of patients
with nonsmall-cell lung cancer and mediastinal lymph node involvement.
J Surg Oncol 1990;43:161–166.
149. Bergh NP, Schersten T. Bronchogenic carcinoma: a follow-up study of
a surgically treated series with special reference to the prognostic significance
of lymph node metastases. Acta Chir Scand 1965;347:1–42.
150. Fisher ER, Gregorio RM, Redmond C, et al. Pathologic findings from
the National Surgical Adjuvant Breast Project (protocol no. 4). III. The
significance of extranodal extension of axillary metastases. Am J Clin
Pathol 1976;65:439–444.
151. Platt JF, Glazer GM, Gross BH, et al. CT evaluation of mediastinal
lymph nodes in lung cancer: influence of the lobar site of the primary
neoplasm. AJR Am J Roentgenol 1987;149:683–686.
152. Baron R, Levitt RG, Sagel SS, et al. Computed tomography in the preoperative
evaluation of bronchogenic carcinoma. Radiology 1982;145:
727–732.
153. Moak GCD, Cockerill EM, Farber MO, et al. Computed tomography
vs standard radiology in the evaluation of mediastinal adenopathy.
Chest 1982;82:69–75.
154. Osborne DR, Korobkin M, Ravin CE, et al. Comparison of plain radiography,
conventional tomography, and computed tomography in
detecting intrathoracic lymph node metastases from lung carcinoma.
Radiology 1982;142:157–161.
155. Rea HH, Shevland JE, House AJ. Accuracy of computed tomographic
scanning in assessment of the mediastinum in bronchial carcinoma.
J Thorac Cardiovasc Surg 1981;81:825–829.
156. Buy JN, Ghossain MA, Poirson F, et al. Computed tomography of mediastinal
lymph nodes in nonsmall cell lung cancer. J Comput Assist
Tomogr 1988;12:545–552.
157. Ikezoe J, Kadowaki K, Morimoto S, et al. Mediastinal lymph node
metastases from nonsmall cell bronchogenic carcinoma: reevaluation
with CT. J Comput Assist Tomogr 1990;14:340–344.
158. Glazer GM, Francis IR, Shirazi KK, et al. Evaluation of the pulmonary
hilum: comparison of conventional radiography, 55 o posterior oblique
tomography, and dynamic computed tomography. J Comput Assist
Tomogr 1983;7:983–989.
159. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma:
analysis of staging in the mediastinum with CT by correlative
lymph node mapping and sampling. Radiology 1992;182:319–323.
160. Lewis JW Jr, Pearlberg JL, Beute GH, et al. Can computed tomography
of the chest stage lung cancer? yes and no. Ann Thorac Surg
1990;49:591–596.
161. Lewis JW Jr, Madrazo BL, Gross SC, et al. The value of radiographic
and computed tomography in the staging of lung carcinoma. Ann
Thorac Surg 1982;34:553–558.
162. Patterson GA, Ginsberg RJ, Poon PY, et al. A prospective evaluation
of magnetic resonance imaging, computed tomography, and mdiastinoscopy
in the preoperative assessment of mediastinal node status in
bronchogenic carcinoma. J Thorac Cardiovasc Surg 1987;94:679–684.
163. Müller NL, Webb WR, Gamsu G. Paratracheal lymphadenopathy:
Radiologic findings and correlation with CT. Radiology 1985;156:
761–765.
164. Thermann M, Poser H, Müller-Hermelink KH, et al. Evaluation of tomography
and mediastinoscopy for the detection of mediastinal lymph
node metastases. Ann Thorac Surg 1984;37:443–447.
165. Hirleman MT, Yiu-Chiu VS, Chiu LC, et al. The resectability of primary
lung carcinoma: a diagnostic staging review. J Comput Tomogr
1980;4:146–163.
166. Lähde S, Hyrynkangas K, Merikanto J, et al. Computed tomography
and mediastinoscopy in the assessment of resectability of lung cancer.
Acta Radiol 1989;30:169–173.
167. Ratto GB, Frola C, Cantoni S, et al. Improving clinical efficacy of
computed tomographic scan in the preoperative assessment of patients
with non-small cell lung cancer. J Thorac Cardiovasc Surg 1990;99:
416–425.
168. Daly BD, Mueller JD, Faling LJ, et al. N2 lung cancer: outcome in
patients with false-negative computed tomographic scans of the chest.
J Thorac Cardiovasc Surg 1993;105:904–910; discussion 910–911.
169. Seely JM, Mayo JR, Miller RR, et al. T1 lung cancer: prevalence of
mediastinal nodal metastases and diagnostic accuracy of CT. Radiology
1993;186:129–132.
170. Daly BD Jr, Faling LJ, Bite G, et al. Mediastinal lymph node evaluation
by computed tomography in lung cancer. J Thorac Cardiovasc Surg
1987;94:664–672.
171. Underwood GH Jr, Hooper RG, Alelbaum SP, et al. Computed tomographic
scanning of the thorax in the staging of bronchogenic carcinoma.
N Engl J Med 1979;300:777–778.
172. Modini C, Passariello R, Iascone C, et al. TNM staging in lung cancer: role
of computed tomography. J Thorac Cardiovasc Surg 1982;84:569–574.
173. Goldstraw P, Kurzer M, Edwards D. Preoperative staging of lung cancer:
role of computed tomography. Thorax 1983;38:10–15.
174. Kamiyoshihara M, Kawashima O, Ishikawa S, et al. Mediastinal
lymph node evaluation by computed tomographic scan in lung cancer.
J Cardiovasc Surg (Torino) 2001;42:119–124.
175. Suzuki K, Nagai K, Yoshida J, et al. Clinical predictors of N2 disease in
the setting of a negative computed tomographic scan in patients with
lung cancer. J Thorac Cardiovasc Surg 1999;117:593–598.
176. Kernstine KH, Stanford W, Mullan BF, et al. PET, CT, and MRI with
Combidex for mediastinal staging in non-small cell lung carcinoma.
Ann Thorac Surg 1999;68:1022–1028.
177. Gupta NC, Graeber GM, Rogers JS II, et al. Comparative efficacy of
positron emission tomography with FDG and computed tomographic
scanning in preoperative staging of non-small cell lung cancer. Ann
Surg 1999;229:286–291.
178. Dales RE, Stark RM, Raman S. Computed tomography to stage lung
cancer. Am Rev Respir Dis 1990;144:1096–1101.
179. Ferguson MK, MacMahon H, Little AG, et al. Regional accuracy of
computed tomography of the mediastinum in staging of lung cancer.
J Thorac Cardiovasc Surg 1986;91:498–504.
180. Nohl HC. An investigation into the lymphatic and vascular spread of
carcinoma of the bronchus. Thorax 1956;11:172–185.
181. Nakata H, Ishimaru H, Nakayama C, et al. Computed tomography for
preoperative evaluations of lung cancer. J Comp Tomogr 1986;10:147–151.
182. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma. Analysis
of 1000 autopsied cases. Cancer 1950;3:74–85.
183. Anderson EE. Nonfunctioning tumors of the adrenal gland. Urol Clin
North Am 1977;4:263–271.
184. Matthews MJ. Problems in morphology and behavior of bronchopulmonary
malignant disease. In: Israel L, Chahinian P, eds. Lung cancer: natural
history, prognosis and therapy . New York: Academic Press, 1976; 23–62.
185. Weiss W, Gillick JS. The metastatic spread of bronchogenic carcinoma
in relation to the interval between resection and death. Chest
1977;71:725–729.
186. Smith RA. Evaluation of long-term results of surgery for bronchial carcinoma.
J Thorac Cardiovasc Surg 1981;82:325–333.
187. Bell JW. Abdominal exploration in one-hundred lung carcinoma suspects
prior to thoracotomy. Ann Surg 1968;167:199–203.
188. Matthews MJ, Kanhouwa S, Pickren J, et al. Frequency of residual and
metastatic tumor in patients undergoing curative surgical resection for
lung cancer. Cancer Chemother Rep 3 1973;4:63–67.
189. Salvatierra A, Baamonde C, Llamas JM, et al. Extrathoracic staging of
bronchogenic carcinoma. Chest 1990;97:1053–1058.
190. Sider L, Horejs D. Frequency of extrathoracic metastases from bronchogenic
carcinoma in patients with normal-sized hilar and mediastinal
lymph nodes on CT. AJR Am J Roentgenol 1988;151:893–895.
191. Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases
from newly diagnosed non-small cell lung cancer. Ann Thorac Surg
1996;62:246–250.
192. Mujoomdar A, Austin JH, Malhotra R, et al. Clinical predictors of
metastatic disease to the brain from non-small cell lung carcinoma:
primary tumor size, cell type, and lymph node metastases. Radiology
2007;242:882–888.
193. Oliver TW Jr, Bernardino ME, Miller JI, et al. Isolated adrenal masses in
nonsmall-cell bronchogenic carcinoma. Radiology 1984;153:217–218.
194. Commons RR, Callaway CP. Adenomas of the adrenal cortex. Arch
Med Interna 1948;81:37–41.
195. Hedeland H, Ostberg G, Hökfelt B. On the prevalence of adrenocortical
adenomas in an autopsy material in relation to hypertension and
diabetes. Acta Med Scand 1968;184:211–214.
196. Glazer HS, Weyman PJ, Sagel SS, et al. Nonfunctioning adrenal masses:
incidental discovery on computed tomography. AJR Am J Roentgenol
1982;139:81–85.
197. Gillams A, Roberts CM, Shaw P, et al. The value of CT scanning and
percutaneous fine needle aspiration of adrenal masses in biopsy-proven
lung cancer. Clin Radiol 1992;46:18–22.
198. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal
masses: CT distinction with attenuation coefficients, size and observer
analysis. Radiology 1991;179:415–418.
199. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal
adenomas from nonadenomas using CT attenuation values. AJR Am J
Roentgenol 1996;166:531–536.
200. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign
from malignant adrenal masses: Multi-detector row CT protocol with
10-minute delay. Radiology 2006;238:578–585.
201. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization
with combined unenhanced and delayed enhanced CT. Radiology
2002;222:629–633.
202. Korobkin M. CT characterization of adrenal masses: the time has
come. Radiology 2000;217:629–632.
203. Jhaveri KS, Wong F, Ghai S, et al. Comparison of CT Histogram
Analysis and Chemical Shift MRI in the Characterization of
Indeterminate Adrenal Nodules. AJR Am J Roentgenol 2006;187:
1303–1308.
204. Whitcomb ME, Barham E, Goldman AL, et al. Indications for mediastinoscopy
in bronchogenic carcinoma. Am Rev Respir Dis 1976;
113:189–195.
205. Duncan KA, Gomersall LN, Weir J. Computed tomography of the
chest in T1N0M0 non-small cell bronchial carcinoma. Br J Radiol
1993;66:20–22.
206. Parker LA, Mauro MA, Delany DJ, et al. Evaluation of T1N0M0 lung
cancer with CT. J Comput Assist Tomogr 1991;15:943–947.
207. Becker GL, Whitlock WL, Schaefer PS, et al. The impact of thoracic
computed tomography in clinically staged T1, N0, M0 chest lesions.
Arch Intern Med 1990;150:557–559.
208. Baker ME, Spritzer C, Blinder R, et al. Benign adrenal lesions mimicking
malignancy on MR imaging: report of two cases. Radiology
1987;163:669–671.
209. Pearlberg JL, Sandler MA, Beute GH, et al. T1N0M0 bronchgenic
carcinoma: assessment by CT. Radiology 1985;157:187–190.
210. Heavey LR, Glazer GM, Gross BH, et al. The role of CT in staging radiographic
T1N0M0 lung cancer. AJR Am J Roentgenol 1986;146:285–290.
211. Conces DJ Jr, Klink JF, Tarver RD, et al. T1N0M0 lung cancer: evaluation
with CT. Radiology 1989;170:643–646.
212. Lähde S, Päivänsalo M, Rainio P. CT for predicting the resectability of
lung cancer. A prospective study. Acta Radiol 1991;32:449–454.
213. Roberts JR, Blum MG, Arildsen R, et al. Prospective comparison of
radiologic, thoracoscopic, and pathologic staging in patients with early
non-small cell lung cancer. Ann Thorac Surg 1999;68:1154–1158.
214. Akamatsu H, Terashima M, Koike T, et al. Staging of primary lung
cancer by computed tomography-guided percutaneous needle cytology
of mediastinal lymph nodes. Ann Thorac Surg 1996;62:352–355.
215. Westcott JL. Percutaneous needle aspiration of hilar and mediastinal
masses. Radiology 1981;141:323–329.
216. Williams RA, Haaga JR, Karagiannis E. CT guided paravertebral biopsy
of the mediastinum. J Comput Assist Tomogr 1984;8:575–578.
217. Patz EF Jr, Erasmus JJ, McAdams HP, et al. Lung cancer staging and
management: comparison of contrast-enhanced and nonenhanced helical
CT of the thorax. Radiology 1999;212:56–60.
218. Pearson F. Staging of the mediastinum. Role of mediastinoscopy and
computed tomography Chest 1993;103:S346–S348.
219. Chapet O, Kong FM, Quint LE, et al. CT-based definition of thoracic
lymph node stations: an atlas from the University of Michigan. Int J
Radiat Oncol Biol Phys 2005;63:170–178.
220. Lee KS, Shim YM, Han J, et al. Primary tumors and mediastinal lymph
nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer:
serial CT findings with pathologic correlation. J Comput Assist Tomogr
2000;24:35–40.
221. Bruzzi JF, Truong M, Zinner R, et al. Short-term restaging of patients
with non-small cell lung cancer receiving chemotherapy. J Thorac Oncol
2006;1:425–429.
222. Milleron B, Westeel V, Quoix E, et al. Complete response following
preoperative chemotherapy for resectable non-small cell lung cancer:
accuracy of clinical assessment using the French trial database. Chest
2005;128:1442–1447.
223. Seto M, Kuriyama K, Kasugai T, et al. Comparison of computed tomography
and pathologic examination for evaluation of response
of primary lung cancer to neoadjuvant therapy. J Thorac Imaging
1999;14:69–73.
224. Siker ML, Tomé WA, Mehta MP. Tumor volume changes on serial
imaging with megavoltage CT for non-small-cell lung cancer during
intensity-modulated radiotherapy: how reliable, consistent, and meaningful
is the effect? Int J Radiat Oncol Biol Phys 2006;66:135–141.
225. Seibert RM, Ramsey CR, Hines JW, et al. A model for predicting lung cancer
response to therapy. Int J Radiat Oncol Biol Phys 2007;67:601–609.
226. Laurent F, Montaudon M, Corneloup O. CT and MRI of Lung
Cancer. Respiration 2006;73:133–142.
227. Patz EF Jr. Imaging bronchogenic carcinoma. Chest 2000;117:
S90–S95.
228. Templeton PA, Caskey CI, Zerhouni EA. Current uses of CT and MR
imaging in the staging of lung cancer. Radiol Clin North Am 1990;
28:631–646.
229. Lau CL, Harpole DH Jr, Patz E. Staging techniques for lung cancer.
Chest Surg Clin N Am 2000;10:781–801.
230. Haramati LB, White CS. MR imaging of lung cancer. Magn Reson
Imaging Clin N Am 2000;8:43–57, viii.
231. Haberkorn U, Schoenberg SO. Imaging of lung cancer with CT, MRT
and PET. Lung Cancer 2001;34:S13–S23.
232. MacDonald SL, Hansell DM. Staging of non-small cell lung cancer:
imaging of intrathoracic disease. Eur J Radiol 2003;45:18–30.
233. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of nonsmall
cell lung cancer: a review of the current evidence. Chest 2003;123:
S137–S146.
234. Rapoport S, Blair DN, McCarthy SM, et al. Brachial plexus: correlation
of MR imaging with CT and pathologic findings. Radiology
1988;167:161–165.
235. Webb WR, Sostman HD. MR imaging of thoracic disease: clinical
uses. Radiology 1992;182:621–630.
236. Gefter WB. Magnetic resonance imaging in the evaluation of lung
cancer. Semin Roentgenol 1990;25:73–84.
237. White CS, Templeton PA, Belani CP. Imaging in lung cancer. Semin
Oncol 1993;20:142–152.
238. White CS, Templeton PA. Radiologic manifestations of bronchogenic
cancer. Clin Chest Med 1993;14:55–67.
239. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by
bronchogenic carcinoma: evaluation with MR imaging. Radiology
1993;187:33–38.
240. Quint LE, Francis IR, Wahl RL, et al. Preoperative staging of nonsmall-
cell carcinoma of the lung: imaging methods. AJR Am J Roentgenol
1995;164:1349–1359.
241. Haggar AM, Pearlberg JL, Froelich JW. Chest-wall invasion by carcinoma
of the lung: detection by MR imaging. AJR Am J Roentgenol
1987;148:1075–1078.
242. Klein JS, Webb WR. The radiologic staging of lung cancer. J Thorac
Imaging 1991;7:29–47.
243. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT
and MR imaging. Radiology 1989;170:637–641.
244. McLoud TC, Filion RB, Edelman RR, et al. MR imaging of superior
sulcus carcinoma. J Comput Assist Tomogr 1989;1989:233–239.
245. Takasugi JE, Rapoport S, Shaw C. Superior sulcus tumors: the role of
imaging. J Thorac Imaging 1989;4:41–48.
246. Freundlich IM, Chasen MH, Varma DG. Magnetic resonance imaging
of pulmonary apical tumors. J Thoracic Imaging 1996;11:
210–222.
247. Castagno AA, Shuman WP. MR imaging in clinically suspected brachial
plexus tumor. AJR Am J Roentgenol 1987;149:1219–1222.
248. Mayr B, Lenhard M, Fink U, et al. Preoperative evaluation of bronchogenic
carcinoma: value of MR in T- and N-staging. Eur J Radiol
1992;14:245–251.
249. McLoud TC. CT of bronchogenic carcinoma: indeterminate mediastinal
invasion. Radiology 1989;173:15–16.
250. Barakos JA, Brown JJ, Higgins CB. MR imaging of secondary
cardiac and paracardiac lesions. AJR Am J Roentgenol 1989; 153:
47–50.
251. Amparo EG, Higgins CB, Farmer D, et al. Gated MRI of cardiac
and paracardiac masses: initial experience. AJR Am J Roentgenol
1984;143:1151–1156.
252. Seo JS, Kim YJ, Choi BW, et al. Usefulness of magnetic resonance imaging
for evaluation of cardiovascular invasion: evaluation of sliding
motion between thoracic mass and adjacent structures on cine MR images.
J Magn Reson Imaging 2005;22:234–241.
253. Glazer GM, Orringer MB, Chenevert TL, et al. Mediastinal lymph
nodes: relaxation time/pathologic correlation and implications
in staging of lung cancer with MR imaging. Radiology 1988;168:
429–431.
254. Webb WR, Jensen BG, Sollitto R, et al. Bronchogenic carcinoma: staging
with MR compared with staging with CT and surgery. Radiology
1985;156:117–124.
255. Heelan RT, Martini N, Westcott JW, et al. Carcinomatous involvement
of the hilum and mediastinum: computed tomographic and magnetic
resonance evaluation. Radiology 1985;156:111–115.
256. Grenier P, Dubray B, Carette M, et al. Preoperative thoracic staging
of lung cancer: CT and MR evaluation. Diagn Interv Radiol 1989;1:
23–28.
257. Bonomo L, Ciccotosto C, Guidotti A, et al. Lung cancer staging: the
role of computed tomography and magnetic resonance imaging. Eur J
Radiol 1996;23:35–45.
258. Boiselle PM. MR imaging of thoracic lymph nodes. A comparison
of computed tomography and positron emission tomography. Magn
Reson Imaging Clin N Am . 2000;8:33–41.
259. Dooms GC, Hricak H, Moseley ME, et al. Characterization of lymphadenopathy
by magnetic resonance relaxation times: preliminary
results. Radiology 1985;155:691–697.
260. Anzai Y, Blackwell KE, Hirschowitz SL, et al. Initial clinical experience
with dextran-coated superparamagnetic iron oxide for detection
of lymph node metastases in patients with head and neck cancer.
Radiology 1994;192:709–715.
261. Harisinghani MG, Saini S, Hahn PF, et al. MR imaging of lymph
nodes in patients with primary abdominal and pelvic malignancies
using ultra small superparamagnetic iron oxide (Combidex). Acad
Radiol 1998;5(suppl 1):S167–S169.
262. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection
of clinically occult lymph-node metastases in prostate cancer. N Engl J
Med 2003;348:2491–2499.
263. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body
metastases to nodes with ferumoxtran 10-enhanced MR imaging:
phase III safety and efficacy study. Radiology 2003;228:777–788.
264. Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance
of nanoparticle-enhanced magnetic resonance imaging in the
diagnosis of lymph node metastases in patients with endometrial and
cervical cancer. J Clin Oncol 2005;23(12):2813–2821,
265. Pannu HK, Wang KP, Borman TL, et al. MR imaging of mediastinal
lymph nodes: evaluation using a superparamagnetic contrast agent.
J Magn Reson Imaging 2000;12:899–904.
266. Herth FJ, Rabe KF, Gasparini S, et al. Transbronchial and transoesophageal
(ultrasound-guided) needle aspirations for the analysis of mediastinal
lesions. Eur Respir J 2006;28:1264–1275.
267. Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR Imaging:
evaluation of patients for metastases. Radiology 2004;233: 139–148.
268. Mitchell DG, Crovello M, Matteucci T, et al. Benign adrenocortical
masses: diagnosis with chemical shift MR imaging. Radiology 1992;
185:345–351.
269. McNicholas MM, Lee MJ, Mayo-Smith WW, et al. An imaging algorithm
for the differential diagnosis of adrenal adenomas and metastases.
AJR Am J Roentgenol 1995;165:1453–1459.
270. Outwater EK, Siegelman ES, Radecki PD, et al. Distinction between
benign and malignant adrenal masses: value of T1-weighted chemicalshift
MR imaging. AJR Am J Roentgenol 1995;65:579–583.
271. Heinz-Peer G, Hönigschnabl S, Schneider B, et al. Characterization
of adrenal masses using MR imaging with histopathologic correlation.
AJR Am J Roentgenol 1999;173:15–22.
272. Caoili EM, Korobkin M, Francis IR, et al. Delayed enhanced CT of lipidpoor
adrenal adenomas. AJR Am J Roentgenol 2000;175:1411–1415.
273. Kim SY, Kim JS, Park HS, et al. Screening of brain metastasis with limited
magnetic resonance imaging (MRI): clinical implications of using
limited brain MRI during initial staging for non-small cell lung cancer
patients. J Korean Med Sci 2005;20:121–126.